Carregant...
Neurotoxic manifestations of high-dose intrathecal gadolinium administration for CT myelogram
Use of intrathecal gadolinium for contrast-enhanced myelography and cisternography remains off-label and is currently not FDA-approved. We report a 70-year-old male who underwent CT myelogram utilizing off-label high-dose intrathecal gadolinium who developed altered mental status and bilateral heari...
Guardat en:
| Publicat a: | Radiol Case Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7452073/ https://ncbi.nlm.nih.gov/pubmed/32874398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radcr.2020.07.084 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|